Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

A Study to Prevent and Improve Sexual Health Concerns for People With Breast Cancer

Not Applicable

Recruiting

Conditions: Improve Sexual Health
Improve Vulvovaginal Health

Interventions: Other: questionnaires
Other: moisturizers

First Posted Date: 2023-06-18

Last Posted Date: 2025-04-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT05910294

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

and more 4 locations

A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain

Phase 2

Recruiting

Conditions: Metastatic Breast Cancer

Interventions: Drug: Tucatinib

First Posted Date: 2023-06-07

Last Posted Date: 2024-08-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 28

Registration Number: NCT05892068

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study of the Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer Treatment

Not Applicable

Recruiting

Conditions: Head and Neck Squamous Cell Carcinoma

Interventions: Other: HRQOL instruments
Other: LENT SOMA instrument

First Posted Date: 2023-06-05

Last Posted Date: 2024-10-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 12

Registration Number: NCT05889091

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma

Phase 2

Active, not recruiting

Conditions: Soft Tissue Sarcoma
Sarcoma,Soft Tissue
Sarcoma
Recurrent Dedifferentiated Liposarcoma
Dedifferentiated Liposarcoma
Unresectable Dedifferentiated Liposarcoma
Metastatic Dedifferentiated Liposarcoma

Interventions: Drug: Etrumadenant
Drug: Zimberelimab

First Posted Date: 2023-06-02

Last Posted Date: 2025-05-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 16

Registration Number: NCT05886634

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States

and more 4 locations

Cord Blood Transplant in Adults With Blood Cancers

Phase 2

Recruiting

Conditions: Acute Myelogenous Leukemia (AML)
Acute Lymphoblastic Leukemia (ALL)
Chronic Myelogenous Leukemia (CML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Disorder
Non-Hodgkin's Lymphoma

Interventions: Drug: Conditioning Chemotherapy
Biological: Cord blood graft

First Posted Date: 2023-06-01

Last Posted Date: 2025-01-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 54

Registration Number: NCT05884333

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study of XmAb23104 in People With Sarcoma

Phase 2

Active, not recruiting

Conditions: Sarcoma

Interventions: Biological: XmAb23104

First Posted Date: 2023-05-30

Last Posted Date: 2023-12-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 6

Registration Number: NCT05879185

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States

and more 4 locations

Mindfulness-oriented Recovery Enhancement (MORE) for Cancer Pain Relief

Phase 2

Recruiting

Conditions: Cancer Pain
Chronic Pain

Interventions: Other: Standard of Care for Pain Management
Behavioral: MORE treatments

First Posted Date: 2023-05-26

Last Posted Date: 2025-05-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 76

Registration Number: NCT05877521

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation

Phase 2

Recruiting

Conditions: Refractory Immune Cytopenias
Blood Cancer

Interventions: Biological: Isatuximab

First Posted Date: 2023-05-24

Last Posted Date: 2025-04-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 25

Registration Number: NCT05873205

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities ), Commack, New York, United States

and more 4 locations

A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

Phase 2

Recruiting

Conditions: Urothelial Carcinoma

Interventions: Drug: Enfortumab Vedotin
Procedure: Radical surgery

First Posted Date: 2023-05-22

Last Posted Date: 2025-05-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 24

Registration Number: NCT05868265

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Phase 1

Active, not recruiting

Conditions: Cutaneous Squamous Cell Carcinoma
Basal Cell Carcinoma
BCC - Basal Cell Carcinoma
Melanoma
Merkel Cell Carcinoma
Metastatic Cancer
Refractory Cancer
BCC
Extramammary Paget Disease
Adnexal Carcinoma

Interventions: Biological: MQ719
Drug: Pembrolizumab

First Posted Date: 2023-05-15

Last Posted Date: 2025-05-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 5

Registration Number: NCT05859074

Locations: 🇺🇸
Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy